Home > Newsletters > Washington Drug Letter > Drugmakers Partner to Standardize GCP Training, Site Qualification
Washington Drug Letter
Oct. 1, 2012 | Vol. 44 No. 39
Drugmakers Partner to Standardize GCP Training, Site Qualification
Clinical trial sponsors could have an easier time qualifying trial sites and training investigators as a new Big Pharma initiative aims to standardize these procedures and support mutual recognition of qualification and training.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.